projects:workgroups:clinicalstudy
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| projects:workgroups:clinicalstudy [2023/07/11 15:10] – zhen | projects:workgroups:clinicalstudy [2025/05/11 15:58] (current) – mikehamidi | ||
|---|---|---|---|
| Line 10: | Line 10: | ||
| **Status**: | **Status**: | ||
| - | - 2022: CTWG was given access to 20 Vivli clinical study packages in the SDTM format. The CTWG team is doing an inventory of those study packages | + | - 2025: CTWG is providing new chapter content (Clinical Trial Data) for the upcoming Book of OHDSI update. |
| - | - 2021: CTWG did an assessment of clinical trial data providers | + | - 2024: The finalization of C-Path SDTM-to-OMOP mappings is underway, with an emphasis on matching concept codes using Usagi. The next step is to execute ETL queries to generate the OMOP CDM tables. Additionally, |
| + | - 2023: The team has transitioned from using Vivli (due to access constraints) data to leveraging SDTM data provided by C-Path for tuberculosis. The development of mapping specifications for the subsequent ETL process will proceed from the initial stages.\\ | ||
| + | - 2022: CTWG has been granted | ||
| + | - 2021: CTWG conducted | ||
| - 2020: Used a synthetic representation of the CDISC SDTM data via PHUSE Test Data. Initial guidance topics were codified but require further testing with diverse real world SDTM data. The CTWG proposals submitted to the OHDSI community in July 2020.\\ | - 2020: Used a synthetic representation of the CDISC SDTM data via PHUSE Test Data. Initial guidance topics were codified but require further testing with diverse real world SDTM data. The CTWG proposals submitted to the OHDSI community in July 2020.\\ | ||
| </ | </ | ||
| Line 25: | Line 28: | ||
| https:// | https:// | ||
| - | Recent WG Updates: [[https:// | + | Recent WG Updates: |
| + | [[https:// | ||
| ---- | ---- | ||
| ==== Meetings ==== | ==== Meetings ==== | ||
| - | {{: | ||
| - | **Spring 23 Schedule**: \\ | + | **Bi-weekly on Fridays from 11:30 AM to 12:00 PM EST (Eastern Standard Time) or 4:30 PM to 5:00 PM UTC (Universal Time Coordinated)** is accessible |
| - | Weekly rotating schedule | + | |
| - | and Fridays, 10AM PT/12AM CT/1PM ET/6PM UK/1AM CST;\\ | + | |
| - | on [[https:// | + | |
| - | For example: | + | *** Note on accessing Teams channel: |
| - | * Jan 27th: 11AM ET\\ | + | |
| - | * Feb 3rd: 1PM ET\\ | + | |
| - | * Feb 10th: 11AM ET\\ | + | |
| - | * Feb 17th: 1PM ET\\ | + | |
| - | + | ||
| - | *** Note on accessing Teams channel | + | |
| * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | ||
| * Alternatively, | * Alternatively, | ||
| + | * Join our WG here if you haven' | ||
| ---- | ---- | ||
| Line 50: | Line 45: | ||
| **WG co-leads**: | **WG co-leads**: | ||
| - | Mike Hamidi, Pfizer, US ([email protected]), | + | Open Spot |
| - | Tom Walpole, ZS Associates, US, | + | |
| and | and | ||
| - | Zhen Lin, Memorial Hermann TMC | Robot Bacon, US ([email protected]) | + | Kenneth Wilkins |
| + | **WG past leads**: | ||
| + | Mike Hamidi, Tom Walpole, Zhen Li, Sonia Araujo | ||
| **Active members**\\ | **Active members**\\ | ||
| - | ^ Name ^ Organization | + | ^ Name ^ Organization |
| - | | Rebecca Baker | CDISC | Austin, TX, USA | | | + | | Chidi Asuzu |
| - | | Ian Braun | + | | Rebecca Baker | CDISC | Austin, TX, USA | | |
| - | | Melissa Cook | Essex Management | + | | Ian Braun |
| - | | Diane Corey | + | | Melissa Cook | Essex Management |
| - | | Kerry Goetz | National Institute of Health; \\ National Eye Institute | + | | Diane Corey |
| - | | Priya Gopal | Flatiron Health | + | | Shital Desai |
| - | | Mike Hamidi | + | | Kerry Goetz | National Institute of Health; \\ National Eye Institute |
| - | | Michael Kallfelz | + | | Mike Hamidi |
| - | | Zhen Lin | MH-TMC/Robot Bacon | Houston, TX, USA | [[https:// | + | | Dan Hartley |
| - | | Zhixin Lun | + | | Ying Huang |
| - | | Terrence McHugh | + | | Asiyah Yu Lin | National Institute of Health |
| - | | Priya Meghrajani | + | | Zhen Lin * | Robot Bacon |
| - | | Daniel Olson | Critical Path Institute | + | | Zhixin Lun | University of Colorado Anschutz Medical Campus |
| - | | Katy Sadowski | + | | Terrence McHugh |
| - | | Philip Solovyev | + | | Priya Meghrajani |
| - | | Cynthia Sung | OHDSI | Seattle, WA, USA|[[https:// | + | | Paul Orona |
| - | | Ramona Walls | Critical Path Institute | + | | Daniel Olson | Critical Path Institute |
| - | | Tom Walpole | + | | Katy Sadowski |
| - | | Kenneth Wilkins | + | | Philip Solovyev |
| - | | Ying Xiao | + | | Cynthia Sung | OHDSI | Seattle, WA, USA |
| - | | Qi Yang | IQVIA | Plymouth Meeting, PA, USA | | | + | | Ramona Walls | Critical Path Institute |
| + | | Tom Walpole | ||
| + | | Kenneth Wilkins | ||
| + | | Ying Xiao | ||
| + | | Qi Yang | IQVIA | Plymouth Meeting, PA, USA | | | ||
| ---- | ---- | ||
| Line 97: | Line 97: | ||
| | Stephen Fortin | | Stephen Fortin | ||
| | Vojtech Huser | National Library of Medicine,\\ National Institutes of Health | Bethesda, MD, USA | | | Vojtech Huser | National Library of Medicine,\\ National Institutes of Health | Bethesda, MD, USA | | ||
| + | | Michael Kallfelz | ||
| | Gregory Klebanov | | Gregory Klebanov | ||
| | Bess LeRoy | | Bess LeRoy | ||
| | James Liddil | | James Liddil | ||
| - | | Asiyah Yu Lin | National Institute of Health | ||
| | Maxim Moinat | | Maxim Moinat | ||
| | Alexandra Orlova | | Alexandra Orlova | ||
projects/workgroups/clinicalstudy.1689088229.txt.gz · Last modified: by zhen